ArticleCancer research and treatment2024

First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer.

Minkyu Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.